Topikal Retinoidler: İzotretinoin
Özet
Topikal izotretinoin (13-cis retinoik asit) tretinoinin cis izomeridir. İsotretinoin ülkemizde %2 eritromisin (isotrexin jel®, munderm jel®) kombinasyonu ile bulunmaktadır. Majör kullanım alanı akne vulgaris olan topikal izotretinoin, melazma, postinflamatuvar hiperpigmentasyon, akne skarları, fotoyaşlanma, Darier hastalığı, oral liken planus, aktinik keratoz, verruka plana gibi hastalıklarda kullanılabilmektedir.
Referanslar
Beckenbach L, Baron JM, Merk HF, Löffler H, Amann PM. Retinoid treatment of skin diseases. Eur J Dermatol. 2015;25(5):384-91.
Bolognia JL, Jorizzo JL, Rapini RP, Callen JP, Horn TD, AJ M. Dermatology. 2 ed. London: Mosby Elsevier; 2008. 1935 p.
Yılmaz İ, Kaplan YC, Karadaş B, Temiz TK, Karaca Ş. Does topical isotretinoin exposure during pregnancy increase the risk of congenital malformations? Turk Arch Dermatol Venereol. 2015;49(2):92-4.
Gilchrest BA. A review of skin ageing and its medical therapy. Br J Dermatol. 1996;135(6):867-75.
Darlenski R, Surber C, Fluhr JW. Topical retinoids in the management of photodamaged skin: from theory to evidence-based practical approach. Br J Dermatol. 2010;163(6):1157-65.
Tüzün Y, Serdaroğlu S, Erdem C, Özpoyraz M, Önder M, S Ö. Dermatolojide Tedavi. İstanbul: Nobel Tıp Kitabevleri; 2010. 962 p.
Elder JT, Fisher GJ, Zhang QY, Eisen D, Krust A, Kastner P,et al.. Retinoic acid receptor gene expression in human skin. J Invest Dermatol. 1991;96(4):425-33.
Chivot M. Retinoid therapy for acne. A comparative review. Am J Clin Dermatol. 2005;6(1):13-9.
Chalker DK, Lesher JL Jr, Smith JG Jr, Klauda HC, Pochi PE, Jacoby WS, et al. Efficacy of topical isotretinoin 0.05% gel in acne vulgaris: results of a multicenter, double-blind investigation. J Am Acad Dermatol. 1987;17(2 Pt 1):251-4.
Krautheim A, Gollnick HP. Acne: topical treatment. Clin Dermatol. 2004;22(5):398-407.
Tüzün Y, Gürer MA, Serdaroğlu S, Oğuz O, VL A. Dermatoloji. İstanbul: Nobel Tıp Kitabevleri; 2008. 1198-9 p.
Kaur GJ, Brar BK, Kumar S, Brar SK, Singh B. Evaluation of the efficacy and safety of oral isotretinoin versus topical isotretinoin in the treatment of plane warts: a randomized open trial. Int J Dermatol. 2017;56(12):1352-1358.
Thielitz A, Gollnick H. Topical retinoids in acne vulgaris: update on efficacy and safety. Am J Clin Dermatol. 2008;9(6):369-81.
Dispenza MC, Wolpert EB, Gilliland KL, Dai JP, Cong Z, Nelson AM,et al.. Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients. J Invest Dermatol. 2012;132(9):2198-205.
Schmidt N, Gans EH. Tretinoin: A Review of Its Anti-inflammatory Properties in the Treatment of Acne. J Clin Aesthet Dermatol. 2011;4(11):22-9.
Leenutaphong V, Nettakul A, Rattanasuwon P. Topical isotretinoin for melasma in Thai patients: a vehicle-controlled clinical trial. J Med Assoc Thai. 1999;82(9):868-75.
Burge SM, Buxton PK. Topical isotretinoin in Darier's disease. Br J Dermatol. 1995;133(6):924-8.
Giustina TA, Stewart JC, Ellis CN, Regezi JA, Annesley T, Woo TY,et al.. Topical application of isotretinoin gel improves oral lichen planus. A double-blind study. Arch Dermatol. 1986;122(5):534-6.
Alirezai M, Dupuy P, Amblard P, Kalis B, Souteyrand P, Frappaz A,et al.. Clinical evaluation of topical isotretinoin in the treatment of actinic keratoses. J Am Acad Dermatol. 1994;30(3):447-51.
Thielitz A, Abdel-Naser MB, Fluhr JW, Zouboulis CC, Gollnick H. Topical retinoids in acne--an evidence-based overview. J Dtsch Dermatol Ges. 2008;6(12):1023-31.
Domínguez J, Hojyo MT, Celayo JL, Domínguez-Soto L, Teixeira F. Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris. Int J Dermatol. 1998;37(1):54-5.
Hughes BR, Norris JF, Cunliffe WJ. A double-blind evaluation of topical isotretinoin 0.05%, benzoyl peroxide gel 5% and placebo in patients with acne. Clin Exp Dermatol. 1992;17(3):165-8.
Glass D, Boorman GC, Stables GI, Cunliffe WJ, Goode K. A placebo-controlled clinical trial to compare a gel containing a combination of isotretinoin (0.05%) and erythromycin (2%) with gels containing isotretinoin (0.05%) or erythromycin (2%) alone in the topical treatment of acne vulgaris. Dermatology. 1999;199(3):242-7.
Taylor CR, Stern RS, Leyden JJ, Gilchrest BA. Photoaging/photodamage and photoprotection. J Am Acad Dermatol. 1990;22(1):1-15.
Cunningham W, Bryce G, Armstrong R, Lesiewicz J, Kim H-J, Sendagorta E. Topical isotretinoin and photodamage. Retinoids: 10 years on. 1991:182-90.
Maddin S, Lauharanta J, Agache P, Burrows L, Zultak M, Bulger L. Isotretinoin improves the appearance of photodamaged skin: results of a 36-week, multicenter, double-blind, placebo-controlled trial. J Am Acad Dermatol. 2000;42(1 Pt 1):56-63.
Callender VD, Preston N, Osborn C, Johnson L, Gottschalk RW. A Meta-analysis to Investigate the Relation Between Fitzpatrick Skin Types and Tolerability of Adapalene-Benzoyl Peroxide Topical Gel in Subjects with Mild or Moderate Acne. J Clin Aesthet Dermatol. 2010;3(8):15-9.
Panchaud A, Csajka C, Merlob P, Schaefer C, Berlin M, De Santis M, et al.Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study. J Clin Pharmacol. 2012;52(12):1844-51.
Jick SS, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders. Lancet. 1993;341(8854):1181-2.
Selcen D, Seidman S, Nigro MA. Otocerebral anomalies associated with topical tretinoin use. Brain Dev. 2000;22(4):218-20.
Lipson AH, Collins F, Webster WS. Multiple congenital defects associated with maternal use of topical tretinoin. Lancet. 1993;341(8856):1352-3.
Colley SM, Walpole I, Fabian VA, Kakulas BA. Topical tretinoin and fetal malformations. Med J Aust. 1998;168(9):467.
Camera G, Pregliasco P. Ear malformation in baby born to mother using tretinoin cream. Lancet. 1992;339(8794):687.
